HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions

The hepatitis B virus (HBV) X gene product trans-activates viral and cellular genes. The X protein (pX) does not bind independently to nucleic acids. The data presented here demonstrate that pX entered into a protein-protein complex with the cellular transcriptional factors CREB and ATF-2 and altered their DNA binding specificities. Although CREB and ATF-2 alone did not bind to the HBV enhancer element, a pX-CREB or pX-ATF-2 complex did bind to the HBV enhancer. Thus, the ability of pX to interact with cellular factors broadened the DNA binding specificity of these regulatory proteins and provides a mechanism for pX to participate in transcriptional regulation. This strategy of altered binding specificity may modify the repertoire of genes that can be regulated by transcriptional factors during viral infection.

[1]  H. Ueno,et al.  Inhibition of PDGF beta receptor signal transduction by coexpression of a truncated receptor , 1991, Science.

[2]  A. Siddiqui,et al.  Functional analysis of a liver-specific enhancer of the hepatitis B virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Habener,et al.  Cyclic‐AMP‐responsive transcriptional activation of CREB‐327 involves interdependent phosphorylated subdomains. , 1990, The EMBO journal.

[4]  Stephen J. DeArmond,et al.  Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication , 1990, Cell.

[5]  J. Ou,et al.  Activation of class I major histocompatibility complex gene expression by hepatitis B virus , 1990, Journal of virology.

[6]  A. Siddiqui,et al.  Hepatitis B virus X protein produced in Escherichia coli is biologically functional , 1990, Journal of virology.

[7]  Michael R. Green,et al.  A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein , 1990, Cell.

[8]  Y. Shaul,et al.  The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax. , 1990, Oncogene.

[9]  P. Mitchell,et al.  Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors , 1990, Nature.

[10]  Tsonwin Hai,et al.  Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. , 1989, Genes & development.

[11]  P. O’Hare,et al.  Herpes simplex virus Vmw65-octamer binding protein interaction: a paradigm for combinatorial control of transcription. , 1989, Virology.

[12]  J. Yee A liver-specific enhancer in the core promoter region of human hepatitis B virus. , 1989, Science.

[13]  W. Herr,et al.  The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16 , 1989, Nature.

[14]  M. Yoshida,et al.  Leucine zipper structure of the protein CRE‐BP1 binding to the cyclic AMP response element in brain. , 1989, The EMBO journal.

[15]  W. Robinson,et al.  Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Y. Shaul,et al.  Cellular factors that interact with the hepatitis B virus enhancer , 1989, Molecular and cellular biology.

[17]  A. Siddiqui,et al.  trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein. , 1989, Virology.

[18]  T. Meyer,et al.  Cyclic AMP-responsive DNA-binding protein: structure based on a cloned placental cDNA. , 1988, Science.

[19]  J. Jameson,et al.  Cyclic AMP and phorbol ester-stimulated transcription mediated by similar DNA elements that bind distinct proteins. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Montminy,et al.  Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB , 1988, Nature.

[21]  P. Hofschneider,et al.  The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. , 1988, Oncogene.

[22]  T. Shenk,et al.  Adenoviral control regions activated by E1A and the cAMP response element bind to the same factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Young-Sun Lin,et al.  Interaction of a common cellular transcription factor, ATF, with regulatory elements in both E1a- and cyclic AMP-inducible promoters. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Rigby,et al.  Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses. , 1988, Genes & development.

[25]  D. Spandau,et al.  trans-activation of viral enhancers by the hepatitis B virus X protein , 1988, Journal of virology.

[26]  J. Twu,et al.  Transcriptional trans-activating function of hepatitis B virus , 1987, Journal of virology.

[27]  A. Siddiqui,et al.  Expression of the hepatitis B virus X gene in mammalian cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Wood,et al.  Firefly luciferase gene: structure and expression in mammalian cells , 1987, Molecular and cellular biology.

[29]  M. Montminy,et al.  Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Siddiqui,et al.  The human hepatitis B virus enhancer requires trans-acting cellular factor(s) for activity , 1986, Molecular and cellular biology.

[31]  W. Rutter,et al.  A human hepatitis B viral enhancer element. , 1985, The EMBO journal.

[32]  R. Erikson,et al.  Protein kinase activity associated with the avian sarcoma virus src gene product. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[33]  E. Ziff Transcription factors: a new family gathers at the cAMP response site. , 1990, Trends in genetics : TIG.

[34]  S. McKnight,et al.  Eukaryotic transcriptional regulatory proteins. , 1989, Annual review of biochemistry.

[35]  J. Flint,et al.  Adenovirus E1A protein paradigm viral transactivator. , 1989, Annual review of genetics.

[36]  H. Varmus,et al.  The molecular biology of the hepatitis B viruses. , 1987, Annual review of biochemistry.